Catalyst Pharmaceuticals Inc (CPRX)
24.69
-0.15
(-0.60%)
USD |
NASDAQ |
Mar 28, 16:00
24.70
+0.01
(+0.04%)
After-Hours: 20:00
Catalyst Pharmaceuticals Shareholders Equity (Quarterly): 727.63M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 679.59M |
| Ionis Pharmaceuticals Inc | 588.35M |
| Halozyme Therapeutics Inc | 363.82M |
| BridgeBio Pharma Inc | -1.468B |
| Recursion Pharmaceuticals Inc | 1.035B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 851.41M |
| Total Liabilities (Quarterly) | 123.78M |
| Current Ratio | 5.168 |